Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Clinically, it can be used to regulate hemorrhagic shock
The mechanism likely involves omega-3's modulation of serotonin and norepinephrine systems, which the hypothalamic thermostat depends on
$299 WEIGHT LOSS Target fat, enhance metabolism and body function
Research applications In-vitro modeling of synergistic GHRH/GHRP receptor cross-talk Pre-clinical study of pulsatile GH-secretagogue dynamics Comparative receptor-pathway research (cAMP vs calcium convergence) Reference standard for analytical characterization of blended preparations Key facts Combines a GHRH-receptor analog with a selective GHS-R1a agonist Nominal 5mg + 5mg per-component loading per vial Components act through mechanistically independent, convergent pathways Supplied as a co-lyophilized research powder for in-vitro use Product specifications Class: GHRH analog + GHRP/ghrelin-receptor agonist research blend Also known as: Mod-GRF + Ipamorelin blend Form: Lyophilized powder vial Purity: 99% (HPLC verified) Testing: Independent third-party HPLC + mass spectrometry Documentation: Certificate of analysis per batch Storage: Store lyophilized at -20C
US$ 22.42
US$ 24.64
US$ 27.19
